BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29036957)

  • 1. [A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of
    Si XB; Lan Y; Qiao L
    Zhonghua Nei Ke Za Zhi; 2017 Oct; 56(10):752-759. PubMed ID: 29036957
    [No Abstract]   [Full Text] [Related]  

  • 2. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
    Poonyam P; Chotivitayatarakorn P; Vilaichone RK
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
    Lü M; Yu S; Deng J; Yan Q; Yang C; Xia G; Zhou X
    PLoS One; 2016; 11(10):e0163743. PubMed ID: 27723762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
    Zhang M; Chen CY; Wang XT; Lyu B
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
    [No Abstract]   [Full Text] [Related]  

  • 5. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
    Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
    Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Zhang MM; Qian W; Qin YY; He J; Zhou YH
    World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-controlled triple-blind study.
    Shavakhi A; Tabesh E; Yaghoutkar A; Hashemi H; Tabesh F; Khodadoostan M; Minakari M; Shavakhi S; Gholamrezaei A
    Helicobacter; 2013 Aug; 18(4):280-4. PubMed ID: 23433200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.
    Zhu R; Chen K; Zheng YY; Zhang HW; Wang JS; Xia YJ; Dai WQ; Wang F; Shen M; Cheng P; Zhang Y; Wang CF; Yang J; Li JJ; Lu J; Zhou YQ; Guo CY
    World J Gastroenterol; 2014 Dec; 20(47):18013-21. PubMed ID: 25548501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
    Luther J; Higgins PD; Schoenfeld PS; Moayyedi P; Vakil N; Chey WD
    Am J Gastroenterol; 2010 Jan; 105(1):65-73. PubMed ID: 19755966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of two kinds of probiotics combined with bismuth quadruple therapy for
    Zhu XY; Du J; Zhao WJ; Wu J; Zhao LW; Meng X; Yang L; Jiao L; Ma H
    Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(28):2246-2249. PubMed ID: 30078279
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy.
    Wang ZH; Gao QY; Fang JY
    J Clin Gastroenterol; 2013 Jan; 47(1):25-32. PubMed ID: 23090045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
    McNicholl AG; Molina-Infante J; Lucendo AJ; Calleja JL; Pérez-Aisa Á; Modolell I; Aldeguer X; Calafat M; Comino L; Ramas M; Callejo Á; Badiola C; Serra J; Gisbert JP
    Helicobacter; 2018 Oct; 23(5):e12529. PubMed ID: 30141228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
    Lin LC; Hsu TH; Huang KW; Tam KW
    World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials.
    Fang HR; Zhang GQ; Cheng JY; Li ZY
    Eur J Pediatr; 2019 Jan; 178(1):7-16. PubMed ID: 30446816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
    Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Zou J; Dong J; Yu X
    Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-bismuth quadruple therapy versus standard triple therapy for Helicobacter pylori eradication: a randomized controlled study].
    Wang S; Wang W; Chu Y; Teng G; Hu F
    Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):576-9. PubMed ID: 24762684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis.
    Dang Y; Reinhardt JD; Zhou X; Zhang G
    PLoS One; 2014; 9(11):e111030. PubMed ID: 25365320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are probiotics useful for therapy of Helicobacter pylori diseases?
    Eslami M; Yousefi B; Kokhaei P; Jazayeri Moghadas A; Sadighi Moghadam B; Arabkari V; Niazi Z
    Comp Immunol Microbiol Infect Dis; 2019 Jun; 64():99-108. PubMed ID: 31174707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.